Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New stapler shows promise in lung cancer surgery

NCT ID NCT07353489

Disease control Sponsor: Ezisurg Medical Co. Ltd. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a powered stapler used during lung cancer surgery in 61 patients. The goal was to see if the device was safe and worked well. Researchers checked for leaks and other complications. The study is complete, but results are not yet published.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
easyEndo™ Powered Single Use Powered Endoscopic Staplers and Cartridges (a surgical stapling device)
What this could lead to
If successful, this could show that the powered stapler is a safe and effective tool for lung cancer surgery, potentially reducing complications.
What could go wrong
This was a small, single-arm study with only 61 patients, so results may not apply to everyone. It also only looked back at past records, not a controlled comparison.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

61 people

The number who actually took part.

Started

Nov 2025

Finished

Jan 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients who underwent thoracic surgery (including lobectomy, segmentectomy, wedge resection, etc.) using easyEndo™ Powered Single-Use Powered Endoscopic Staplers and Cartridges at our hospital. * Surgery date was on or after January 1, 2024. * Patients with complete medical records (including demographic data, surgical details, perioperative management, and follow-up information). * Patients who completed a 1-year postoperative follow-up, with available and valid follow-up data Exclusion Criteria: * Patients who used other brands or types of endoscopic staplers instead of easyEndo™ Powered Single-Use Powered Endoscopic Staplers and Cartridges during surgery. * Surgery date was before January 1, 2024. * Patients with incomplete medical records or missing key information (e.g., unclear surgical procedures, unrecorded stapler use details, lost to follow-up before 1 year). * Patients with severe underlying diseases that may affect postoperative outcomes or follow-up, such as end-stage heart, liver, or kidney disease, severe coagulation disorders, or uncontrolled malignant tumors (other than the primary disease requiring thoracic surgery). * Patients with allergies to the materials of easyEndo™ staplers or cartridges, or who experienced adverse reactions related to stapler material allergies intraoperatively or postoperatively.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lung cancer (NSCLC) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lung cancer (NSCLC)

Contacts and locations

Locations

  • Affiliated Hospital of Jining Medical University

    Jining, Shandong, 272000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.